跳至主要内容
临床试验/NL-OMON24554
NL-OMON24554尚未招募不适用

Pharmacokinetic and pharmacodynamic target attainment of amoxicillin(-clavulanic acid) in pleural empyema fluid and complicated parapneumonic effusion

ot applicable.0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Age = 18 years
  • -Diagnosed with pleural empyema or complicated parapneumonic effusion, based on the criteria mentioned below, and in need of pleural fluid drainage.
  • opresence of pus or positive Gram’s stain or culture from the pleural fluid.
  • opleural pH<7.2 or pleural fluid glucose value <2.2 mmol/l or pleural fluid LDH value >1000 IU/L
  • -Receiving IV amoxicillin 1000mg 4 times daily or amoxicillin-clavulanic acid 1000/200mg 4 times daily; dosage if necessary adapted to renal function
  • -Able and willing to give informed consent (or consent by family member or legal representative)

排除标准

  • -Critically ill patients admitted to the ICU, or patients of the general ward who became critically ill and got transferred to the ICU during the duration of the study.
  • -Pre-existing ipsilateral pleural effusion or other cause of pleural effusion (e.g. cancer) more likely.

研究者

发起方
ot applicable.

相似试验